Patients Stopping Weight-Loss Jabs Gain Back Pounds Four Times Faster Than Those on Conventional Diets

Fresh analysis indicates that people who stop using new weight-loss injections like Wegovy and Mounjaro can put back on lost weight at a significantly accelerated pace than those who stop conventional diet and exercise regimens.

Research printed in a major health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"People buying such treatments must be informed of the danger of fast weight regain when the medication is stopped," warns researcher Dr. Susan Jebb.

This pace of recovery suggests a return to starting mass in about a year and a half.

Analyzing Approaches

The study, which reviewed dozens of studies involving thousands of participants, compared the effects of GLP-1 agonists with older methods.

Researchers emphasize that people who shed pounds through dieting generally see a more gradual weight regain—around 100 grams monthly—once they finish.

Explaining the Fast Regain

Doctors believe the way of the jabs accounts for the accelerated weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing the hormone concentrations far above than the body's typical production could lead to the body to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.

"Stopping of this medication leads to appetite is no longer kept in check, making overeating far more likely."

A Lifelong Condition?

The NHS recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians argue that, given the significant potential of weight regain, the therapy is often long-term.

This perspective is echoed by drug manufacturers, who say that the results "underscore the persistent character of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

Users who have come off the medication report a intense resurgence of hunger.

"It felt as if something flipping and you're instantly starving," recalled a patient.

This difficulty is compounded if patients have not developed lasting lifestyle or habit modifications during treatment.

Significant Use

Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the past year, with interest remaining high.

• Adoption is greater among women compared to males.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the drugs through private prescriptions rather than public health services.

Finally, clinicians stress that while these medications are powerful tools for shedding pounds, they are not a permanent fix and maintained weight loss hinges on ongoing lifestyle support.